Authors:
LINDE T
SANDHAGEN B
WIKSTROM B
DANIELSON BG
Citation: T. Linde et al., THE REQUIRED DOSE OF ERYTHROPOIETIN DURING RENAL ANEMIA TREATMENT IS RELATED TO THE DEGREE OF IMPAIRMENT IN ERYTHROCYTE DEFORMABILITY, Nephrology, dialysis, transplantation, 12(11), 1997, pp. 2375-2379
Authors:
BESHARA S
LETOCHA H
LINDE T
WIKSTROM B
SANDHAGEN B
NILSSON S
DANIELSON BG
Citation: S. Beshara et al., ANEMIA ASSOCIATED WITH ADVANCED PROSTATIC ADENOCARCINOMA - EFFECTS OFRECOMBINANT-HUMAN-ERYTHROPOIETIN, The Prostate, 31(3), 1997, pp. 153-160
Authors:
FADUL JEM
SANDHAGEN B
LINDE T
VESSBY B
WIKSTROM B
DANIELSON BG
Citation: Jem. Fadul et al., EFFECTS OF LDL APHERESIS ON BLOOD RHEOLOGY IN 2 PATIENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA, Blood purification, 15(3), 1997, pp. 182-187
Citation: T. Linde et Kh. Mild, MEASUREMENT OF LOW-FREQUENCY MAGNETIC-FIELDS FROM DIGITAL CELLULAR TELEPHONES, Bioelectromagnetics, 18(2), 1997, pp. 184-186
Authors:
LINDE T
SANDHAGEN B
WIKSTROM B
DANIELSON BG
Citation: T. Linde et al., THE REQUIRED DOSE OF ERYTHROPOIETIN (EPO) DURING RENAL ANEMIA TREATMENT IS RELATED TO THE DEGREE OF IMPAIRMENT IN ERYTHROCYTE DEFORMABILITY, Journal of the American Society of Nephrology, 7(9), 1996, pp. 1205-1205
Authors:
LINDE T
SANDHAGEN B
HAGG A
MORLIN C
DANIELSON BG
Citation: T. Linde et al., DECREASED BLOOD-VISCOSITY AND SERUM LEVELS OF ERYTHROPOIETIN AFTER ANTIHYPERTENSIVE TREATMENT WITH AMLODIPINE OR METOPROLOL - RESULTS OF A CROSS-OVER STUDY, Journal of human hypertension, 10(3), 1996, pp. 199-205
Authors:
LINDE T
SANDHAGEN B
HAGG A
MORLIN C
DANIELSON BG
Citation: T. Linde et al., IMPROVED FLOW PROPERTIES OF BLOOD AFTER ANTIHYPERTENSIVE TREATMENT WITH AMLODIPIN OR METOPROLOL, Kidney international, 49(3), 1996, pp. 924-924
Authors:
LINDE T
WIKSTROM B
ANDERSSON LG
DANIELSON BG
Citation: T. Linde et al., RENAL ANEMIA TREATMENT WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN INCREASES CARDIAC-OUTPUT IN PATIENTS WITH ISCHEMIC-HEART-DISEASE, Scandinavian journal of urology and nephrology, 30(2), 1996, pp. 115-120
Authors:
LINDE T
RONQUIST G
SANDHAGEN B
WIKSTROM B
FRITHZ G
PETTERSSON L
DANIELSON BG
Citation: T. Linde et al., TREATMENT OF RENAL ANEMIA WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN RESULTS IN DECREASED RED-CELL UPTAKE OF CA-45, Nephron, 68(4), 1994, pp. 419-426
Authors:
LINDE T
SANDHAGEN B
BRATTEBY LE
DEVERDIER CH
DANIELSON BG
WIKSTROM B
Citation: T. Linde et al., REDUCED OXYGEN-AFFINITY CONTRIBUTES TO IMPROVED OXYGEN RELEASING CAPACITY DURING ERYTHROPOIETIN TREATMENT OF RENAL ANEMIA, Nephrology, dialysis, transplantation, 8(6), 1993, pp. 524-529
Authors:
LINDE T
SANDHAGEN B
HAGG A
MORLIN C
WIKSTROM B
DANIELSON BG
Citation: T. Linde et al., BLOOD-VISCOSITY AND PERIPHERAL VASCULAR-RESISTANCE IN PATIENTS WITH UNTREATED ESSENTIAL-HYPERTENSION, Journal of hypertension, 11(7), 1993, pp. 731-736